Samsung Medical Center: Esophageal Squamous Cell Carcinoma trials

The registry lists 10 Esophageal Squamous Cell Carcinoma studies with Samsung Medical Center as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 6No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Retrospective Cohort Study of Patients Who Underwent Curative-intent Esophagectomy for ESCC at a Tertiary Referral Center in South KoreaCompletedNCT07201571
• Neoadjuvant Nivolumab for Operable Esophageal CarcinomaStatus unknownNCT03987815Phase 2
• Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal CancerStatus unknownNCT03377400Phase 2
• Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell CarcinomaActive, not recruitingNCT03306901Not applicable
• Genome-wide Association StudyWithdrawnNCT01498757
• Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell CarcinomaCompletedNCT01474642Phase 2
• Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT01472419
• Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell CancerCompletedNCT01469598Phase 2
• Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell CarcinomaStatus unknownNCT01467921Phase 2
• Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT00816634Phase 2